SUBSCRIBE
SUBSCRIBE

Tenax Therapeutics

NEWS
Business
BioSpace Movers & Shakers, Feb. 4
Biopharma and life sciences companies strengthen their boards and leadership teams with these Movers & Shakers.
February 3, 2022
 · 
9 min read
 · 
Alex Keown
Business
New CEOs Named at Two Biopharma Companies
Scorpion Therapeutics announced its new CEO Dr. Axel Hoos while Tenax Therapeutics named Christopher Giordano as its new chief executive.
July 8, 2021
 · 
2 min read
 · 
Vanessa Doctor, RN
IN THE PRESS
Business
Oxygen Biotherapeutics, Inc. Closes the Acquisition Of Phyxius Pharma Assets Related To Levosimendan, Taps New CEO
November 14, 2013
 · 
5 min read
Bio NC
Oxygen Biotherapeutics, Inc. Receives $6 Million in Net Proceeds From Warrant Exercises
November 8, 2013
 · 
1 min read
Drug Development
Phyxium Pharma in Conjunction With Oxygen Biotherapeutics, Inc. Announces New Evidence That Levosimendan Can Reduce Mortality in Heart Surgery Patients
October 30, 2013
 · 
1 min read
Deals
Oxygen Biotherapeutics, Inc. Snags Certain Assets of Phyxius Pharma to Pursue Potential $600 Million Cardiovascular Market
October 22, 2013
 · 
7 min read
Policy
Oxygen Biotherapeutics, Inc. Submits to FDA Results of Requested Nonclinical Studies
September 23, 2013
 · 
1 min read
Bio NC
Oxygen Biotherapeutics, Inc. Strengthens Balance Sheet Through $4.6 Million Debt Conversion
September 18, 2013
 · 
1 min read
Bio NC
Oxygen Biotherapeutics, Inc. Issued U.S. Patent for Dermatologic Indications
September 10, 2013
 · 
1 min read
Bio NC
Oxygen Biotherapeutics, Inc. Issues Letter to Shareholders
August 7, 2013
 · 
1 min read
BioCapital
Oxygen Biotherapeutics, Inc. to Present at FSX Investment Conference in Fort Lauderdale on July 25th, 2013
July 23, 2013
 · 
1 min read
Bio NC
Oxygen Biotherapeutics, Inc. Prices Public Offering With Gross Proceeds of $5.4 Million
July 22, 2013
 · 
1 min read
Load More
JOBS